Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Shabnam, Rehman"'
Publikováno v:
Clinical Case Reports, Vol 11, Iss 12, Pp n/a-n/a (2023)
Key Clinical Message Lymphadenopathy following recent immunization is usually regional. Generalized lymphadenopathy should arouse suspicion for alternative underlying pathology. Prostate adenocarcinoma should be considered in the differential diagnos
Externí odkaz:
https://doaj.org/article/d2fd6ec43ba349d2aef7895adef78cdb
Autor:
Shabnam Rehman, Grace K. Dy
Publikováno v:
European Medical Journal, Vol 4, Iss 1, Pp 100-111 (2019)
Cancer treatment paradigms have evolved over recent years with an emphasis on personalised medicine. Targeted agents are being used to improve treatment outcomes and quality of life. For the treatment of non-small cell lung cancer, several agents wit
Externí odkaz:
https://doaj.org/article/e7ef6bc306d44eec9f5c055640a53b41
Publikováno v:
Cancer Research. 82:P5-18
Background: Pneumonitis is significant toxicity of immune checkpoint inhibitors (ICIs). Lately, multiple clinical trials have demonstrated that neoadjuvant chemoimmunotherapy improves pathological complete response rate in high-risk early-stage tripl
Publikováno v:
Cancer Research. 82:P5-18
Background: Immune checkpoint inhibitors (ICIs) are known to cause various irreversible endocrinopathies. Lately, multiple clinical trials have demonstrated that the addition of ICI to the standard neoadjuvant chemotherapy improves pathological compl
Autor:
Catherine Jones, Sariya Wongsaengsak, Nusrat Jahan, Shabnam Rehman, Fred Hardwicke, Sakshi Singal
Publikováno v:
Cancer Research. 81:PS9-18
Background: Chemoimmunotherapy (CPI+C) is an important addition to the triple-negative breast cancer (TNBC) treatment. However, immune checkpoint inhibitors (CPIs) are frequently associated with significant endocrine toxicities. We conducted a system
Publikováno v:
Blood. 140:12031-12032
Autor:
Lukman Tijani, Rafiullah Khan, Nusrat Jahan, Catherine Jones, Shabnam Rehman, Somedeb Ball, Francis Mogollon-Duffo
Publikováno v:
Cancer Research. 80:P3-11
Background: Trastuzumab Emtansine (T-DM1) is a HER2-targeted antibody-drug conjugate consisting of anti-HER2 IgG1 antibody trastuzumab and maytansine derivative DM-1. The trastuzumab part of T-DM1 inhibits HER2 receptor signaling, mediates antibody-d
Autor:
Rafiullah Khan, Lukman Tijani, Shabnam Rehman, Nusrat Jahan, Fred Hardwicke, Francis Mogollon-Duffo
Publikováno v:
Cancer Research. 80:P5-14
Background: Trastuzumab Emtansine (T-DM1) is a HER2 targeted antibody-drug conjugate consisting of anti-HER2 IgG1 antibody trastuzumab and maytansine derivative DM-1. Trastuzumab inhibits HER2 receptor signaling and mediates antibody-dependent cell-m
Publikováno v:
Cureus
Background Peripheral neuropathy (PN), especially peripheral sensory neuropathy (PSN), is significant toxicity of taxanes, the most used class of microtubule inhibitors for human epidermal growth factor receptor 2 (HER2)-positive breast cancer patien
Autor:
Shabnam Rehman, Nusrat Jahan
Publikováno v:
BMJ Case Rep
Metastatic tumours of the distal extremities, also known as acrometastases, are rare. The majority of the acrometastases involve bones—involvement of the soft tissues of the feet and hands is extremely rare. We report a case of clear cell renal cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d9876515452532873f7e4ebdb40210
https://europepmc.org/articles/PMC7583075/
https://europepmc.org/articles/PMC7583075/